Keyphrases
Mupirocin
100%
Liposomal
68%
Liposomes
65%
Remote Loading
43%
Nanoliposomes
35%
Quantitative Structure-property Relationship
35%
Cannabidiol
33%
Pharmacokinetics
33%
Antibiotics
31%
Therapeutic Efficacy
23%
Neisseria Gonorrhoeae
20%
Liposomal Drugs
19%
Parenteral Administration
18%
Osteoarthritis
18%
Pilot Randomized Controlled Trial
16%
Therapeutic Potential
16%
Solubilizing Agent
16%
PEGylated Nanoliposome
16%
Multidrug-resistant Bacteria
16%
In Vitro Susceptibility
16%
New Drug Candidate
16%
Computer Modeling
16%
Systemic Treatment
16%
Staphylococcal Infections
16%
Liposomal Delivery
16%
Experimental Validation
16%
In Silico Prediction
16%
Prediction Validation
16%
Drug Candidates
16%
Computer-aided Design
16%
Relationship Modeling
16%
Pain Management
16%
Compassion
16%
Targeted Antibiotic
16%
Tumor Targeting
16%
Gut Microbiome
16%
Cancer Nanotechnology
16%
Loading Efficiency
12%
Lipid Ratios
12%
Plasma Concentration
10%
Well-being
8%
Topical Administration
8%
Active Pharmaceutical Ingredients
8%
High Concentration
7%
Cross-resistance
7%
High Mass Loading
6%
Hydroxypropyl-β-cyclodextrin (HP-β-CD)
6%
Nanodrug
5%
Loading Model
5%
Leakage Model
5%
Pharmacology, Toxicology and Pharmaceutical Science
Mupirocin
83%
Liposome
75%
Infection
23%
Pharmacokinetic
20%
Malignant Neoplasm
17%
Staphylococcal Infection
16%
Systemic Treatment
16%
Solubilizer
16%
Microbiome
16%
Neoplasm
16%
Diseases
13%
Staphylococcus aureus
13%
Elimination
12%
Liposomal Drug Delivery
8%
Antibiotics
6%
Combination Therapy
6%
Cyclodextrin
6%
Active Pharmaceutical Ingredient
5%
Nanomedicine
5%
Meticillin
5%
